RIJSWIJK, Netherlands--(BUSINESS WIRE)--Feb 9, 2026--
The Netherlands-based MedTech company UV Smart has officially received clearance from the United States Food and Drug Administration (FDA). With this 510(k) clearance, UV Smart is launching its groundbreaking UV-C technology for the high-level disinfection of TEE probes in the United States: The D60 is the first UV-C high-level disinfection device in the world to receive FDA clearance for this application.
Click to Gallery
UV Smart D60 with TEE probes
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209198084/en/
What started as an innovative idea between two friends, has quickly grown into an international organization that is now active in 35 countries and is the market leader in its segment. With the support of investor Chris Oomen (founder of Optiver), UV Smart proves that Dutch innovation can make healthcare better and affordable worldwide.
From hours to minutes
The FDA clearance applies to the UV Smart D60: A system that disinfects medical TEE probes, sensitive medical instruments for heart examination used in cardiology, with UV-C light. Where current cleaning & disinfection with harsh chemicals can often take approximately two hours, the D60 achieves high-level disinfection in just two minutes using UV-C light. For healthcare providers, the D60 represents a significant improvement in efficiency and workflow; the D60 is the first device of its kind to receive FDA 510(K) clearance for high-level disinfection of TEE probes.
“This clearance will help fulfill the need in U.S. healthcare for validated options that reduce manual workload, improve safety, and support more efficient clinical workflows,” says co-founder Thijs Kea.
Efficiency as a revenue model
UV Smart is redefining hospital efficiency, seamlessly scaling facility capacity while fortifying safety for healthcare workers. Its equipment enables faster disinfection cycles, allowing more patients to be treated per day. In addition, the system eliminates the cost of chemicals and reduces wear & tear on costly cardiology equipment.
With its entry into to the United States, UV Smart is entering the next phase of its international growth strategy. UV Smart is demonstrating that chemical-free high-level disinfection can support both operational efficiency and long-term cost control in healthcare settings.
About UV Smart
UV Smart Technologies B.V. is a Dutch MedTech company that makes healthcare safer and more affordable with innovative UV-C high-level disinfection products. Since its founding in 2017 by Daan Hoek and Thijs Kea, the company has grown into an international player with approximately thirty employees in the Netherlands, Germany and the United Kingdom.
The portfolio, consisting of the D25, D45 and D60, is specifically aimed at the disinfection of cardiology, gynecology, TEE and ENT equipment respectively. UV Smart now supplies hospitals and clinics in 35 countries. With the forthcoming expansion to the United States, the company is aiming for strong global growth.
Images:More images of the D60 and its founders are available on request.
About the 510(k) approval:https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K251354
UV Smart's UV-C light
UV Smart D60 with TEE probes
UV Smart D60
Founder UV Smart
NEW YORK (AP) — A big rally for global stock markets that began in Asia on Monday petered out by the time trading got to Wall Street.
The S&P 500 was virtually unchanged in morning trading. The Dow Jones Industrial Average was down 154 points, or 0.3%, as of 10 a.m. Eastern time, and the Nasdaq composite was 0.1% higher.
The modest moves followed a 3.9% burst higher for Japan’s Nikkei 225 to a record. Stocks rallied there following a landslide victory for the prime minister’s political party in a parliamentary election. The thought is that will give Sanae Takaichi more power to push through reforms that will boost the economy and market.
On Wall Street, the U.S. stock market took a pause following its own big rally on Friday, which was its best day since May. Several concerns still hang over the market, including criticism that stocks have simply become too expensive. The S&P 500 remains near its all-time high set last month.
Worries are also heavy about whether all the huge spending by Big Tech and other companies on AI can produce enough profit to make the investments worth it.
The majority of stocks fell on Wall Street Monday, but some of the winners of that rush into AI helped prop up the market. Chip companies rose, for example, with Nvidia up 3.3% and Broadcom up 1.5%. They were two of the strongest forces pushing upward on the S&P 500.
Kroger climbed 8.2% after the grocer named a former Walmart executive as its new chief executive officer.
On the losing end was Hims & Hers, which sank 26.9% after Novo Nordisk filed a lawsuit and alleged Hims & Hers is unlawfully selling versions of its weight-loss treatments. Novo Nordisk’s stock that trades in the United States rose 5.8%.
Hims & Hers in turn said, “Big Phama is weaponizing the US judicial system to limit consumer choice” in a post on the X account for the company's communications team.
Workday fell 7.5% after the AI platform said its CEO, Carl Eschenbach, is stepping down. Company Co-founder Aneel Bhusri is returning as chief executive.
Transocean slipped 0.8% after the offshore drilling company said it would buy Valaris in an all-stock deal valued at $5.8 billion. Valaris leaped 22.5%.
In the bond market, Treasury yields held relatively steady ahead of several potentially market-moving reports coming later in the week. The U.S. government will offer the latest monthly update on the health of the job market on Wednesday. Friday will bring the latest monthly reading of inflation at the consumer level.
Either report could sway expectations for what the Federal Reserve will do with interest rates. The Fed has put its cuts to interest rates on hold, but a weakening of the job market could push it to resume more quickly. Too-hot inflation, on the other hand, could keep it on hold for longer.
One of the reasons the U.S. stock market remains close to records is the expectation that the Fed will continue cutting interest rates later this year. Lower rates can give the economy a boost, though they can also worsen inflation.
The yield on the 10-year Treasury held at 4.22%, where it was late Friday.
Other markets that had whipped through more violent moves over recent weeks were showing some relative calm.
Gold added 1.5% to climb back above $5,000 per ounce. It’s been swinging sharply after roughly doubling in price over 12 months and ,it has bounced between $4,500 and nearly $5,600. Silver, whose price has been even wilder, rose 5.5% Monday.
Bitcoin dipped back toward $69,000 after climbing above $71,000 over the weekend. It had dropped close to $60,000 last week, more than halfway below its record set in October.
In stock markets abroad, indexes jumped across Asia with Japan’s surge. South Korea’s Kospi leaped 4.1%, while stocks rose 1.8% in Hong Kong and 1.4% in Shanghai.
The moves were more modest in Europe, where indexes were mixed.
AP Videojournalist Mayuko Ono and AP Business Writer Elaine Kurtenbach contributed.
Specialist Anthony Matesic works at his post on the floor of the New York Stock Exchange, Friday, Feb. 6, 2026. (AP Photo/Richard Drew)
A security guard stands guard at the gate of Tokyo Stock Exchange building, Monday, Feb. 9, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)
People walk in front of an electronic stock board showing Japan's Nikkei index at a securities firm Monday, Feb. 9, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)
A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm, Monday, Feb. 9, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)
People stand in front of an electronic stock board showing Japan's Nikkei index at a securities firm, Monday, Feb. 9, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)
A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm Monday, Feb. 9, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)
